Biological Testing TRIZ Cases

A molecular trap captures free biotin via selective binding agents, preventing false results from high biotin levels in patient samples.

Controller checks sensor mounting and measurement component status using reference resistor and open state diagnostics.

A rapid integrity testing method uses reducing agents and proteases to assess keratinized structures before analyte quantitation.

A magnetic assay device differentiates bound from unbound labeled reagents using time-varying magnetic fields to drive distinct optical signals.

A sensor device heating element provides a larger heating effect near the inlet than near the outlet to ensure uniform temperature distribution.

Cholesterol analysis quantifies extracellular vesicles by replacing nanoparticle tracking with biochemical assays to resolve throughput bottlenecks.

A one-step immunoassay uses a multivalent bridge antigen to capture and detect specific IgG antibodies without washing steps.

A particle analyzer uses axial light loss measurements to differentiate hard-to-ghost cells from mature red blood cells in blood samples.

Controlled freezing and thawing cycles enhance membrane stability and scalability, extending shelf life while maintaining baseline stability.

Detecting ITPR1-binding autoantibodies resolves diagnostic ambiguity by replacing subjective symptom analysis with objective immunological assays.

Zeolite particulates and a gel barrier block silver ions, extending sensor life beyond four weeks.

Spin probes attach to oilfield chemicals to enable precise detection via electron paramagnetic resonance.

Matching epitopes in a reference zone normalize test signals, compensating for sample concentration and temperature variations to improve measurement precision.

A contact structure body uses a separator and probe to link electrodes to circuits.

A biosensor measures target molecule concentration in crowded solutions using biolayer interferometry.

Tape stripping extracts antimicrobial peptides from the stratum corneum, enabling objective quantitation of skin defense mechanisms without invasive procedures.

Fluorescent aptamer conjugates detect pathogens on surfaces, resolving the trade-off between high detection specificity and operational efficiency.

Linearity control composition uses stabilized red blood cells to mono-disperse white blood cell analogs via gentle mixing.

A urea-based synthetic urine composition incorporates biocides to control bacterial growth and maintain shelf stability.

Solid substrate multiplex ELISA immobilizes capture antibodies to detect multiple analytes simultaneously, reducing signal interference and time consumption.

CTR-Test method determines optimal drug concentrations using statistical distribution parameters for in vitro efficacy assessment.

Countdown biosensors measure analyte concentration via spontaneous photoswitching rates, eliminating ambiguity between target and sensor levels.

Test system sets clotting start and wait times to prevent latent fibrin formation, ensuring complete coagulation before centrifugation.

A digoxin immunochromatographic test strip uses antibody-fluorescent microsphere complexes on a glass fiber mat for rapid sample detection.

A blood state analysis device evaluates coagulation capacity using dielectric constant measurements of whole blood samples.

Blood-based desmosterol measurements replace invasive cerebrospinal fluid analysis to diagnose Alzheimer's disease while reducing patient burden.

An ionic surfactant polymer binds interfering substances to improve measurement accuracy without requiring sample dilution.

Hemolytic agents lyse red blood cells to enable optical platelet detection via forward and side scattered light intensities.

A peptide detection scheduling method optimizes oligomer selection by weighting probabilities based on predicted chromatographic elution times.

Dissolving rare earth nanocrystals in an enhancer solution forms nanomicelles that amplify fluorescence signals by up to 900 times.

Testing serum for Ipo5, Ran, and Kpnβ1 enables early cancer detection before tumors establish, avoiding complex imaging.

Automated analysis of electrostatic potential data replaces manual inspection, improving prediction accuracy and screening throughput.

A 3D microtissue screening method evaluates drug combinations using patient-derived models to assess physiological effects and potential synergies.

Using magnetic particle movement distance to evaluate medium suitability, resolving the trade-off between cell retention performance and recovery efficiency.

D-amino acid substrates eliminate endogenous interference, achieving high sensitivity and specificity in hormone assays.

Polyoxyethylene surfactants reduce blank variation in immunoassays, improving low-concentration accuracy and reproducibility.

A particle reagent placed in a separate container reacts with the sample before transfer to the test device.

A test container with a magnetic diaphragm and driving element homogenizes consumable samples for automated analysis.

A specimen analyzer print unit outputs analysis results on paper to ensure clear visibility.

A method isolating soluble and insoluble protein fractions to identify interactions via proximity co-aggregation signatures.

Measuring device registers unique magazine identifiers to track test unit consumption without complex code rewriting mechanisms.

A bienzyme biosensor amplifies glutamate signals via a closed enzymatic loop, resolving the trade-off between detection sensitivity and response time.

A high-throughput assay detects CatSper modulators by measuring sperm motility changes in calcium-free test solutions.

Accelerometer feedback detects device tilt and vibration to prevent measurement inaccuracies during handheld immunoassay testing.

A cationic detergent surfactant pretreatment exposes HCV core polypeptide epitopes for immediate binding compound detection.

A cell-based assay measures antibody binding via FRET signals while tracking reporter gene expression in a single vial.

High resolution mass spectrometry quantifies peptide impurities that co-elute during chromatography, enabling precise pharmaceutical quality control.